However, in addition to assess high CVD risk, measurement of CRP from DBS could have clinically added value in the follow-up of e.g. rheumatoid disease, Crohn’s disease, and sarcoidosis, from the comfort of the patients home. This evidence concerns the gene CRP and Crohn disease.